Nucleozin is a small molecule inhibitor that targets the influenza A nucleoprotein (NP), an essential RNA-binding protein for viral replication. It has demonstrated antiviral activity in both cell-based assays and animal models, making it a valuable research tool for studying influenza pathogenesis and developing novel therapeutics.
